Welcome to
B2B Health Innovation Market 2023
ANI, the Portuguese National Innovation Agency with the support of the Enterprise Europe Network, in partnership with the Health Cluster Portugal (HCP) are promoting a LONG THERM matchmaking event, OPEN UNTIL May 31st, 2023 (Online).
Topics addressed
- 1. Partners for development and testbed for health innovation
2. Final technology users
3. Suppliers of health data
4. Clinical trials
5. Partners in R&D projects
6. Pre-commercial procurement challenges
- Identify potential partners for R&D projects and technology transfer
- Explore opportunities to expand business and to commercialize new products, services, and technologies
- Exchange best practices and knowledge on innovative healthcare services, policy, funding models and instruments, and pre-commercial procurement opportunities.
- Publish and showcase your products, projects, services or business needs to event participants
- Initiate and arrange promising pre-scheduled 1:1 meetings at the event
- Generate fresh leads and meet new contacts in a time and cost-efficient way
- Stay one step ahead of your competitors by being seen and visibly present at the event
- Registration until May 31st
- Check the marketplace and request meetings with other participants
- Deadline to request meetings: May, 31st
- Please reply to all requests and accept/reject promptly!
- Online B2B meetings: continuously until 31st May
Why participate?
Participants will have the opportunity to meet bilaterally in pre-arranged 20 minutes talks online:
How can you benefit from this event?
This event is organised in the framework of Health Cluster Portugal - Meetings with Health Innovation 2023:
"Advancing High-Value Health Outcomes”.
The event is an opportunity to network with professionals from highly specialized medical and health companies and institutions from all over Europe.
IMPORTANT! - Participation is free of charge, but registrations are limited!
For more information and registration to the Conference go to: Meetings with Health Innovation "Advancing High-Value Health Outcomes"